Capsaicin for Advanced TRPV1 and KDM1A Research Workflows
2026-05-07
Capsaicin ((E)-Capsaicin) is a dual-acting research tool enabling precision TRPV1 ion channel activation and potent KDM1A/LSD1 inhibition. Explore how APExBIO's Capsaicin powers robust pain, inflammation, and gastric cancer models—plus expert troubleshooting and workflow innovations.
Ionizing Radiation Alters Neural Differentiation via PI3K-ST
2026-05-06
This study uncovers that ionizing radiation induces altered neuronal differentiation in C17.2 mouse neural stem-like cells via the PI3K-STAT3-mGluR1 pathway. These mechanistic insights highlight the complex impact of radiation on neurogenesis, with implications for radiotherapy side effects and neural epigenetic regulation.
Bortezomib (PS-341): Precision Proteasome Inhibition for Can
2026-05-06
Bortezomib (PS-341) stands out as a reversible 20S proteasome inhibitor, enabling robust investigation of apoptosis and proteasome-regulated cellular processes in cancer models. This article unpacks advanced protocols, troubleshooting strategies, and key innovations that differentiate Bortezomib-driven workflows, with actionable guidance for multiple myeloma and pyrimidine metabolism research.
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract
2026-05-05
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is designed to prevent protein degradation during extraction and analysis, especially where divalent cation-sensitive assays are required. It should be used in workflows needing broad-spectrum protease inhibition without EDTA, but is not suitable for protocols where DMSO is incompatible or in workflows not requiring protease inhibition.
Bay 11-7821: Optimizing NF-κB Pathway & Inflammation Researc
2026-05-05
Bay 11-7821 (BAY 11-7082) delivers precise, reproducible inhibition of the NF-κB pathway, empowering researchers to dissect inflammatory signaling and apoptosis regulation with confidence. This guide translates recent bench breakthroughs and troubleshooting strategies into actionable laboratory protocols for inflammatory, cancer, and immune studies.
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn
2026-05-04
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses the challenge of protein degradation during extraction and handling, particularly in workflows sensitive to divalent cations. It should be used for applications like Western blotting, co-immunoprecipitation, and kinase assays where broad-spectrum inhibition is needed, but is not intended for protocols requiring EDTA-mediated metalloprotease inhibition.
RSL3: Glutathione Peroxidase 4 Inhibitor for Precision Ferro
2026-05-04
Unlock the power of (1S,3R)-RSL3—APExBIO’s potent glutathione peroxidase 4 inhibitor—for robust, selective ferroptosis induction in cancer research. This guide delivers actionable workflows, troubleshooting insights, and the latest translational breakthroughs to accelerate your oxidative stress and synthetic lethality assays.
Substance P in Precision Bioassays: Innovations Beyond Pain
2026-05-03
Explore the multifaceted role of Substance P, a tachykinin neuropeptide, in high-precision bioassay design. Uncover advanced analytical strategies and new insights into assay interference, setting this article apart from conventional pain transmission research.
Applied Workflows with YC-1 in Hypoxia and Cancer Research
2026-05-02
YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol empowers researchers to dissect hypoxic signaling and tumor angiogenesis with dual-action inhibition and activation properties. Learn how APExBIO’s high-purity YC-1 streamlines robust in vitro assays and maximizes reproducibility in advanced cancer biology applications.
Sulfo-Cy5 Carboxylic Acid: Fluorescent Dye for Life Sciences
2026-05-02
Sulfo-Cy5 carboxylic acid delivers unmatched hydrophilicity and minimal quenching, optimizing protein and peptide labeling for high-sensitivity fluorescence imaging. This guide translates current research and real-world protocols into actionable workflows, ensuring reproducible results across neuroscience, immunology, and advanced vaccine development.
E-64d (SKU A1903): Reliable Cysteine Protease Inhibition in
2026-05-01
Explore how E-64d (SKU A1903), a membrane-permeable cysteine protease inhibitor, addresses core challenges in apoptosis, neuroprotection, and platelet assays. This article provides scenario-driven guidance for optimizing protocols, interpreting data, and selecting high-quality reagents—grounded in evidence and best practices—helping researchers achieve reproducible, insightful results.
Firefly Luciferase mRNA (ARCA, 5-moUTP): Applied Workflows &
2026-04-30
Firefly Luciferase mRNA (ARCA, 5-moUTP) delivers unmatched bioluminescence, immune evasion, and translational efficiency for gene expression, cell viability, and in vivo imaging assays. This guide translates cutting-edge research and product engineering into actionable protocols and troubleshooting strategies for robust, reproducible results.
Sulfamonomethoxine Toxicity in Aquatic Species: Ecosystem Ri
2026-04-30
This article analyzes the acute and chronic toxicity of sulfamonomethoxine (SMM) across five aquatic species, revealing marked sensitivity differences—especially among microalgae and cladocerans. The study's systematic assay design and its implications for environmental risk assessment are discussed, with practical connections to optimizing buffer systems in aquatic toxicology.
RAS/PI3K Mutations Sensitize Ovarian Cancer to PARP/NAMPT In
2026-04-29
This study reveals that epithelial ovarian cancer cells with RAS/PI3K pathway mutations exhibit increased sensitivity to combined PARP and NAMPT inhibition. The findings offer a mechanistic rationale for targeted combination therapies, highlighting how metabolic vulnerabilities in specific genetic backgrounds can be leveraged to overcome resistance in ovarian cancer maintenance treatment.
Anti-ROR1 Antibody (Zilovertamab): Mechanistic Depth for Nex
2026-04-29
Explore the advanced mechanistic underpinnings and experimental protocols of Anti-ROR1 Antibody (Zilovertamab) in cancer research. This cornerstone article delivers unique insight into Wnt5a-induced ROR1 signaling inhibition and guides the selection of optimal assay parameters.
466 records 20/32 page Previous Next First page 上5页 1617181920 下5页 Last page